Our previous study of Neuronatin (NNAT), a proteolipid involved in the regulation of Ca2+-channels, showed that high expression of NNAT was significantly associated with poor prognosis for overall survival in BC patients [41]. This evidence concerns the gene NNAT and breast cancer.